Videos

Drs Alice Wei and Skye Mayo discuss options for induction therapy prior to surgery in iCCA.

Drs Keri Lunsford and Maria Majella Doyle explore clinical data on neoadjuvant treatment before transplantation in patients with iCCA.

Dr Cristina Ferrone, a surgical oncologist, queries Dr Ethan Ludmir about the feasibility of surgical resection after locoregional radiation therapy in a patient with CCA.

Dr Michael Soulen discusses the balance between the number of core biopsies needed for adequate tissue acquisition for biomarker testing and safety concerns for the patient.

A distinguished panel discusses ways in which interventional oncologists and pathologists can work together, using novel interventional radiology technologies, to optimize tissue acquisition for biomarker testing in CCA.

Dr Timothy Yap comments on the challenges in using ctDNA in detecting FGFR fusions and the potential of ctRNA in detecting molecular alterations that can drive therapy and monitor both response and resistance to therapy.

Dr Jesus Bañales discusses advances in our understanding of molecular targets that can be used to direct therapy against novel molecular pathways in CCA.

Dr V. Sahai discusses how to move forward with immune-oncology approaches in biliary tract cancers, including key investigations that are needed to improve outcomes with immunotherapy in CCA.

Understanding more about the molecular biology of cholangiocarcinoma will improve its treatment